INCYTE CORP — Director's Dealing 2025

Mar 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2025-03-25

Reporting Person: Trotta Matteo (EVP, GM, Dermatology US)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-25	Common Stock	F	537	$62.08	Disposed	9937	Direct

Footnotes

F1: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.

F2: This includes an aggregate of 8,517 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.